Opening SLE - A BRIEF SUMMARY - A CLINICIAN'S PERSPECTIVE - DR. JOHN MATHEW
SLE - A BRIEF SUMMARY - A CLINICIAN'S PERSPECTIVE - DR. JOHN MATHEW
- Length
- 1 h 4 min
- Level
- Undergraduate
- Recorded
- Christian Medical College Vellore2024
Chapter 1 of 10: Before the lecture
Examines EULAR/ACR classification criteria and treatment protocols for systemic lupus erythematosus.
Systemic lupus erythematosus presents with highly variable clinical manifestations that require careful classification and risk stratification. Dr. John Mathew examines the 2019 EULAR/ACR criteria, highlighting how phenotypic scoring and antinuclear antibody positivity guide diagnosis across diverse patient cohorts. The session details treatment protocols for renal and non-renal organ involvement, balancing the efficacy of glucocorticoids and immunosuppressive agents against cumulative toxicity. Subsequent discussion addresses specialized clinical scenarios, including neuropsychiatric lupus management, pregnancy risks in autoimmune disease, and vaccination considerations for immunosuppressed patients.
Systemic lupus erythematosus presents with highly variable clinical manifestations that require careful classification and risk stratification. Dr. John Mathew examines the 2019 EULAR/ACR criteria, highlighting how phenotypic scoring and antinuclear antibody positivity guide diagnosis across diverse patient cohorts. The session details treatment protocols for renal and non-renal organ involvement, balancing the efficacy of glucocorticoids and immunosuppressive agents against cumulative toxicity. Subsequent discussion addresses specialized clinical scenarios, including neuropsychiatric lupus management, pregnancy risks in autoimmune disease, and vaccination considerations for immunosuppressed patients.
Validation of the 2019 EULAR/ACR classification criteria for SLE in ANA-positive Chinese patients
Treatment patterns in paediatric and adult patients with SLE: a retrospective claims database study in the USA
Lumina cohort study
Racial/Ethnic Differences in Prevalence of and Time to Onset of SLE Manifestations: The California Lupus Surveillance Project (CLSP)
Lupus 1997;6(2):84–95
Ann N Y Acad Sci. 2007;1108:166

This lecture
Lecture 24 of 39 of PG LECTURES.
Choose a node to see how it connects to this lecture. What comes before is on the leftat the top. What comes after is on the rightat the bottom. The ring is what it teaches. People and places are above. Other lectures and books are below.
Press a chosen node again to open it.
Your comment is kept while you sign up.Sign in
N Engl J Med 2007; 357:580-587
ACR EULAR 2023 Recommendations on Management of Lupus
ACR/EULAR recommendations on management of SLE
Neuropsychiatric manifestations are not uncommon in Indian lupus patients and negatively affect quality of life
Prevalence, risk factors, and impact on mortality of NPSLE: a prospective, single-center study
Neuropsychiatric syndromes in SLE: a meta-analysis
Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with SLE
EULAR recommendations for the management of SLE with neuropsychiatric manifestations
Mycophenolate mofetil and deflazacort-induced remission in NPSLE: a experience from a tertiary care teaching hospital in southern India
Oral corticosteroid use during pregnancy and risk of preterm birth